Clinical Trial Update: Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating topotecan for recurrent extensive-stage small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED